6
Oct
2026
Inventia Healthcare Limited
Exhibitor at CPHI Milan 2026 stand 20H12, Finished Dosage & Formulation
About Us
Categories
-
Country/Region:India
-
On CPHI since:2017
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 20H12, Finished Dosage & Formulation
Products Featured at CPHI Milan 2026
-
Product Nitrofurantoin Macrobid Capsule 75:25
Nitrofurantoin Macrobid Capsule 75:25 DMF
Macrobid® Capsules (Alvogen Inc, US) -
Product Tolterodine Tartrate 2/4 mg ER Capsules
Tolterodine Tartrate 2/4 mg ER Capsules DMF
Detrol® Tolterodine ER Capsules 4 mg (LA by Pharmacia Upjohn of Pfizer NY,US) -
Product Gliclazide SR DC Granules 18.18% w/w
Gliclazide SR DC Granules 18.18% w/w CEP
Diamicron® Gliclazide MR Tablets 30, 60 mg (Servier, France) -
Product Metformin HCl 1000 mg SR + Glimepiride 1/2 mg Tablets
Metformin HCl 1000 mg SR + Glimepiride 1/2 mg Tablets DMF -
Product Metformin HCl 500 mg SR + Pioglitazone HCl 15/30 mg Tablets
Metformin HCl 500 mg SR + Pioglitazone HCl 15/30 mg Tablets Non DMF
Glucophage® Metformin HCl XR Tablets 500 mg (BMS, US) + Actos® Pioglitazone HCl Tablets 30 mg (Takeda, US)
Inventia Healthcare Limited Resources (1)
-
Brochure Global Product List
Our product Portfolio
